Evidence map›Paper›PMID 38865420›Full record

ArticlePLOS global public health2024

"I found out about Zika virus after she was born." Women's experiences of risk communication during the Zika virus epidemic in Brazil, Colombia, and Puerto Rico.

María Consuelo Miranda Montoya, Claudia Hormiga Sánchez, Ester Paiva Souto, Edna Acosta Pérez, Gustavo Corrêa Matta, Marcela Daza, Gabriela Lopes Gama, Camila Pimentel, Marcela Mercado, Angélica María Amado Niño and 4 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

María Consuelo Miranda MontoyaFacultad de Salud, Universidad Industrial de Santander, Fundación INFOVIDA, Bucaramanga, Colombia.ORCID https://orcid.org/0000-0001-5730-0723
Claudia Hormiga SánchezFacultad de Ciencias de la Salud, Universidad Autónoma de Bucaramanga, Fundación INFOVIDA, Bucaramanga, Colombia.ORCID https://orcid.org/0000-0002-8723-666X
Ester Paiva SoutoInterdisciplinary Centre for Public Health Emergencies (NIESP-CEE-FIOCRUZ), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-8168-8585
Edna Acosta PérezGraduate School of Public Health / Hispanic Alliance for Clinical and Translational Research, Medical Science Campus, University of Puerto Rico, San Juan, Puerto Rico.ORCID https://orcid.org/0000-0001-7101-3157
Gustavo Corrêa MattaInterdisciplinary Centre for Public Health Emergencies (NIESP-CEE-FIOCRUZ), Center for Data and Knowledge Integration for Health (CIDACS/FIOCRUZ-Bahia), Rio de Janeiro, Brazil.
Marcela DazaGrupo de Salud Materna y Perinatal, Instituto Nacional de Salud, Bogotá, Colombia.
Gabriela Lopes GamaProfessor Joaquim Amorim Neto Research Institute (IPESQ), UNIFACISA University Center, Paraíba, Brazil.ORCID https://orcid.org/0000-0002-7352-6711
Camila PimentelLaboratory for Studies on Drugs, Vulnerabilities and Social Markers (LED), Department of Public Health (NESC), Aggeu Magalhães Institute-Fiocruz Pernambuco, Recife, Pernambuco, Brazil.
Marcela MercadoDirección de Investigación en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Angélica María Amado NiñoFacultad de Salud, Departamento de Salud Pública, Universidad Industrial de Santander, Bucaramanga, Colombia.ORCID https://orcid.org/0000-0001-8313-5469
Luz Marina LeegstraHeidelberger Institut für Global Health, Universitätsklinikum Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-1524-9568
Elena Marbán CastroISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0002-9715-0595
Olivia C MandersRollins School of Public Health, Hubert Department of Global Health, Emory University, Atlanta, Georgia, United States of America.
Lauren MaxwellHeidelberger Institut für Global Health, Universitätsklinikum Heidelberg, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-0777-2092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Providing accurate, evidence-based information to women with Zika infection during pregnancy was problematic because of the high degree of uncertainty in the diagnosis of the infection and the associated risk. The 2015-17 Zika virus epidemic overwhelmingly affected women in countries with limited access to safe abortion. Understanding women's perspectives on risk communication during pregnancy in the context of an emerging pathogen can help inform risk communication in response to future outbreaks that affect fetal or child development. We conducted a cross-sectional qualitative interview study with 73 women from 7 locations in Brazil, Colombia, and Puerto Rico to understand women's experiences of Zika virus (ZIKV) test and outcome-related communication during the ZIKV pandemic. We used thematic analysis to analyze the in-depth interviews. Participants in Brazil and Colombia reported that the healthcare system's lack of preparation and organization in communicating ZIKV test results and associated adverse outcomes led to their feeling abandoned and alone in confronting the challenges of a ZIKV-affected pregnancy. In contrast, participants in Puerto Rico reported that the regular testing schedules and clear, well-planned communication between the care team and between providers and pregnant women helped them to feel they could prepare for a ZIKV-affected pregnancy. Communication of the risk associated with an emerging pathogen suspected to affect pregnancy and developmental outcomes is a fraught issue. Public health authorities and healthcare providers should work together in the interpandemic period to understand families' preferences for risk communication during pregnancy in the presence of uncertainty and develop a community-informed plan for risk communication.

Identifiers

PMID38865420
PMCPMC11168637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.